Abstract
We have previously demonstrated that feeding six-week-old female mice with 20 units of human insulin every 2 - 3 days for 15 or 30 days induced an active mechanism of suppression through the generation of regulatory T cells that reduced the number of successful diabetic transfers in irradiated NOD recipients. In the present study, we analyzed the effects of antigen dosage and the critical period of cell injection to obtain protection. The effects of the dose of insulin feeding were therefore compared during cotransfer experiments of 5 x 10(6) T cells from diabetic mice and 5 x 10(6) T cells from the spleen of mice receiving 10 units, 20 units, or 40 units of insulin or saline every 2 - 3 days for 15 days. Only T lymphocytes from mice fed with 20 units conferred active cellular protection during adoptive transfer with a significant delay in diabetes onset (p = 0.002). No significant difference was noticed during histological analysis of pancreatic glands, indicating tha insulitis was not prevented. However, mice receiving T lymphocytes from the 20 units of insulin-fed animals had a milder form of inflammation, with a significantly lower percentage of severely infiltrated islets. Injecting regulatory T cells 7 days and 14 days af...Continue Reading
References
May 1, 1991·Diabetologia·C H ThivoletJ Orgiazzi
Nov 15, 1991·Proceedings of the National Academy of Sciences of the United States of America·Z J ZhangH L Weiner
Jan 1, 1990·Annual Review of Immunology·L Castaño, G S Eisenbarth
Jun 1, 1990·Journal of Autoimmunity·R J Keller
Dec 23, 1983·Science·J P PalmerT L Paquette
Jan 1, 1980·Jikken dobutsu. Experimental animals·S MakinoY Tochino
Jun 1, 1995·Journal of Autoimmunity·N FabienC Thivolet
Oct 1, 1994·Journal of Autoimmunity·I BergerotC Thivolet
Jan 1, 1994·Annual Review of Immunology·H L WeinerD A Hafler
Jul 5, 1994·Proceedings of the National Academy of Sciences of the United States of America·A Friedman, H L Weiner
Jun 1, 1993·Journal of Autoimmunity·N N ShehadehK J Lafferty
Citations
May 1, 2008·Current Diabetes Reports·Peter AchenbachUNKNOWN Pre-POINT Study Group
Aug 19, 2000·Lancet·L ChaillousP Saï
Jun 2, 2011·Nature Reviews. Drug Discovery·Frank Waldron-Lynch, Kevan C Herold
Nov 9, 2005·The Journal of Experimental Medicine·Matthias G von Herrath, Gerald T Nepom
Oct 6, 1997·Proceedings of the National Academy of Sciences of the United States of America·K J BeckerJ M Hallenbeck
Sep 26, 2008·Lancet·Kirsti Näntö-SalonenOlli Simell
Sep 19, 2008·Molecular Immunology·Hwa-Jung YiSin-Hyeog Im
Jun 19, 2013·Journal of Autoimmunity·Tobias BoettlerMatthias von Herrath
Aug 23, 2005·Immunity·Lisl K M ShodaHuub T C Kreuwel
Jan 28, 2015·Nature Reviews. Endocrinology·James C Reed, Kevan C Herold
Apr 1, 2004·Endocrinology and Metabolism Clinics of North America·Urs ChristenMatthias G von Herrath
Feb 19, 2000·Gene Therapy·C M Seroogy, C G Fathman
Jan 8, 2004·Annals of Medicine·Arno HänninenChristian Kurts
Oct 18, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·S H ImS Fuchs